Phenotypic Variability Related to Mutations in Riboflavin Transporter in Brazilian Children: Pediatric Case Series

Abstract

Brown–Vialetto–Van Laere syndrome or riboflavin transporter deficiency is a rare and genetically determined condition that results in a spectrum of neurological signs and symptoms from generalized muscle weakness to cranial nerve involvement with medullary symptoms and respiratory failure. Most patients have SLC52A3 gene biallelic variants, but some of them may have impairment of SLC52A2 gene, both related to the cell transport of riboflavin. We report the case of three unrelated Brazilian patients under 18 years of age with this diagnosis confirmed by molecular genetic sequencing. We observed that the clinical manifestations found were compatible with those already described in the literature by age group. Unusual findings of retinitis pigmentosa and immunodeficiency were identified related to pathogenic variants in the SLC52A2 gene. All patients received riboflavin replacement at a therapeutic dose without gastrointestinal intolerance and with clinical improvement after starting treatment.

Keywords

Brown–Vialetto–Van Laere syndrome - Fazio Londe syndrome - riboflavin transporter - riboflavin supplementation

Publikationsverlauf

Eingereicht: 16. August 2023

Angenommen: 26. März 2024

Artikel online veröffentlicht:
24. April 2024

• References

• 1 Foley AR, Menezes MP, Pandraud A. et al. Treatable childhood neuronopathy caused by mutations in riboflavin transporter RFVT2. Brain 2014; 137 (Pt 1): 44-56
• 2 Brown CH. Infantile amyotrophic lateral sclerosis of the family type. J Nerv Ment Dis 1894; 19: 707-716
• 3 Vialetto E. Contributo alla forma ereditaria della paralisi bulbare progressive. Riv Sper Fren 1936; 40: 1-24
• 4 Van Laere J. [Familial progressive chronic bulbo-pontine paralysis with deafness. A case of Klippel-Trenaunay syndrome in siblings of the same family. Diagnostic and genetic problems]. Rev Neurol (Paris) 1966; 115 (02) 289-295
• 5 Boudin G, Pépin B, Vernant JC, Gautier B, Gouérou H. [Familial case of chronic progressive bulbo-pontine paralysis with deafness]. Rev Neurol (Paris) 1971; 124 (01) 90-92
• 6 Bosch AM, Stroek K, Abeling NG, Waterham HR, Ijlst L, Wanders RJ. The Brown-Vialetto-Van Laere and Fazio Londe syndrome revisited: natural history, genetics, treatment and future perspectives. Orphanet J Rare Dis 2012; 7: 83
• 7 Mosegaard S, Bruun GH, Flyvbjerg KF. et al. An intronic variation in SLC52A1 causes exon skipping and transient riboflavin-responsive multiple acyl-CoA dehydrogenation deficiency. Mol Genet Metab 2017; 122 (04) 182-188
• 8 Fennessy JR, Cornett KMD, Burns J, Menezes MP. Benefit of high-dose oral riboflavin therapy in riboflavin transporter deficiency. J Peripher Nerv Syst 2023; 28 (03) 308-316
• 9 Subramanian VS, Sabui S, Teafatiller T, Bohl JA, Said HM. Structure/functional aspects of the human riboflavin transporter-3 (SLC52A3): role of the predicted glycosylation and substrate-interacting sites. Am J Physiol Cell Physiol 2017; 313 (02) C228-C238
• 10 Bamaga AK, Maamari RN, Culican SM, Shinawi M, Golumbek PT. Child Neurology: Brown-Vialetto-Van Laere syndrome: dramatic visual recovery after delayed riboflavin therapy. Neurology 2018; 91 (20) 938-941
• 11 Manole A, Fratta P, Houlden H. Recent advances in bulbar syndromes: genetic causes and disease mechanisms. Curr Opin Neurol 2014; 27 (05) 506-514
• 12 Yao Y, Yonezawa A, Yoshimatsu H, Masuda S, Katsura T, Inui K. Identification and comparative functional characterization of a new human riboflavin transporter hRFT3 expressed in the brain. J Nutr 2010; 140 (07) 1220-1226
• 13 Yamamoto S, Inoue K, Ohta KY. et al. Identification and functional characterization of rat riboflavin transporter 2. J Biochem 2009; 145 (04) 437-443
• 14 Colasuonno F, Marioli C, Tartaglia M, Bertini E, Compagnucci C, Moreno S. New insights into the neurodegeneration mechanisms underlying riboflavin transporter deficiency (RTD): involvement of energy dysmetabolism and cytoskeletal derangement. Biomedicines 2022; 10 (06) 1329
• 15 Bandettini Di Poggio M, Monti Bragadin M, Reni L. et al. Brown-Vialetto-Van Laere syndrome: clinical and neuroradiological findings of a genetically proven patient. Amyotroph Lateral Scler Frontotemporal Degener 2014; 15 (1–2): 141-144
• 16 Kendall FP, McCreary EK, Provance PG. Muscles: Testing and Function, with Posture and Pain. 5th ed.. Lippincott Williams & Wilkins; 2005
• 17 O'Callaghan B, Bosch AM, Houlden H. An update on the genetics, clinical presentation, and pathomechanisms of human riboflavin transporter deficiency. J Inherit Metab Dis 2019; 42 (04) 598-607
• 18 Kranthi P, Garuda BR, Gopi S, Kumar TS. Brown-Vialetto-Van Laere syndrome: a rare case report of MND mimic. Neurol India 2020; 68 (05) 1217-1219
• 19 Amir F, Atzinger C, Massey K. et al. The clinical journey of patients with riboflavin transporter deficiency type 2. J Child Neurol 2020; 35 (04) 283-290
• 20 Srour M, Putorti ML, Schwartzentruber J. et al; FORGE Canada Consortium. Mutations in riboflavin transporter present with severe sensory loss and deafness in childhood. Muscle Nerve 2014; 50 (05) 775-779
• 21 Cosgrove J, Datta S, Busby M. Adult onset Brown-Vialetto-Van Laere syndrome with opsoclonus and a novel heterozygous mutation: a case report. Clin Neurol Neurosurg 2015; 128: 1-3
• 22 Alberca R, Montero C, Ibañez A, Segura DI, Miranda-Nieves G. Progressive bulbar paralysis associated with neural deafness. A nosological entity. Arch Neurol 1980; 37 (04) 214-216
• 23 Manole A, Jaunmuktane Z, Hargreaves I. et al. Clinical, pathological and functional characterization of riboflavin-responsive neuropathy. Brain 2017; 140 (11) 2820-2837
• 24 Rizzo F, Ramirez A, Compagnucci C. et al. Genome-wide RNA-seq of iPSC-derived motor neurons indicates selective cytoskeletal perturbation in Brown-Vialetto disease that is partially rescued by riboflavin. Sci Rep 2017; 7: 46271
• 25 Becherucci V, Bacci GM, Marziali E, Sodi A, Bambi F, Caputo R. The new era of therapeutic strategies for the treatment of retinitis pigmentosa: a narrative review of pathomolecular mechanisms for the development of cell-based therapies. Biomedicines 2023; 11 (10) 2656
• 26 Schramm M, Wiegmann K, Schramm S. et al. Riboflavin (vitamin B2 ) deficiency impairs NADPH oxidase 2 (Nox2) priming and defense against Listeria monocytogenes . Eur J Immunol 2014; 44 (03) 728-741
• 27 Mazur-Bialy AI, Buchala B, Plytycz B. Riboflavin deprivation inhibits macrophage viability and activity - a study on the RAW 264.7 cell line. Br J Nutr 2013; 110 (03) 509-514
• 28 Allison T, Roncero I, Forsyth R, Coffman K, Pichon JL. Brown-Vialetto-Van Laere syndrome as a mimic of neuroimmune disorders: 3 cases from the clinic and review of the literature. J Child Neurol 2017; 32 (06) 528-532
• 29 Quaio CRDC, Moreira CM, Novo-Filho GM. et al. Diagnostic power and clinical impact of exome sequencing in a cohort of 500 patients with rare diseases. Am J Med Genet C Semin Med Genet 2020; 184 (04) 955-964
• 30 Sardh E, Harper P, Penz C. et al. SSIEM 2016 Annual Symposium - Abstracts. J Inherit Metab Dis 2016; 39: 35-284
• 31 Console L, Tolomeo M, Cosco J, Massey K, Barile M, Indiveri C. Impact of natural mutations on the riboflavin transporter 2 and their relevance to human riboflavin transporter deficiency 2. IUBMB Life 2022; 74 (07) 618-628
• 32 Yilmaz O, Gundogdu O, Tunc AA, Cakir M. Audiologic results of child with BVVL syndrome. Ann Med Res 2023; 30 (08) 827-978
• 33 Bosch AM, Abeling NGGM, Ijlst L. et al. Brown-Vialetto-Van Laere and Fazio Londe syndrome is associated with a riboflavin transporter defect mimicking mild MADD: a new inborn error of metabolism with potential treatment. J Inherit Metab Dis 2011; 34 (01) 159-164
• 34 Green P, Wiseman M, Crow YJ. et al. Brown-Vialetto-Van Laere syndrome, a ponto-bulbar palsy with deafness, is caused by mutations in c20orf54. Am J Hum Genet 2010; 86 (03) 485-489
• 35 Johnson JO, Gibbs JR, Van Maldergem L, Houlden H, Singleton AB. Exome sequencing in Brown-Vialetto-van Laere syndrome. Am J Hum Genet 2010; 87 (04) 567-569 , author reply 569–570
• 36 Malafronte P, Clark HB, Castaneda-Sanchez I, Raisanen J, Hatanpaa KJ. Brown-Vialetto-Van Laere syndrome: clinical and neuropathologic findings with immunohistochemistry for C20orf54 in three affected patients. Pediatr Dev Pathol 2013; 16 (05) 364-371
• 37 Hossain MA, Obaid A, Rifai M. et al. Early onset of Fazio-Londe syndrome: the first case report from the Arabian Peninsula. Hum Genome Var 2017; 4: 17018
• 38 Frederick AL, Yang JH, Schneider S. et al. To be or no B2: a rare cause of stridor and weakness in a toddler. Child Neurol Open 2021; 8: 2329048X2110307
• 39 Bashford JA, Chowdhury FA, Shaw CE. Remarkable motor recovery after riboflavin therapy in adult-onset Brown-Vialetto-Van Laere syndrome. Pract Neurol 2017; 17 (01) 53-56
• 40 Carey G, Kuchcinski G, Gauvrit F. et al. Three cases of adult-onset Brown-Vialetto-Van Laere syndrome: Novel variants in SLC52A3 gene and MRI abnormalities. Neuromuscul Disord 2021; 31 (08) 752-755